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Abstract The ‘‘trabecular bone score’’ (TBS) indirectly
explores bone quality, independently of bone mineral
density (BMD). We investigated the effects of anthropo-
metric and metabolic parameters on TBS in 87 overweight/
obese men. We assessed BMD and TBS by DXA, and
some parameters of glucose metabolism, sex-and cal-
ciotropic hormone levels. Regression models were adjusted
for either age and BMI, or age and waist circumference, or
age and waist/hip ratio, also considering BMI [35 (y/n)
and metabolic syndrome (MS) (y/n). Correlations between
TBS and parameters studied were higher when correcting
for waist circumference, although not significant in sub-
jects with BMI [35. The analysis of covariance showed
that the same model always had a higher adjusted r-square
index. BMD at lumbar spine and total hip, fasting glucose,
bioavailable testosterone, and sex hormone-binding glob-
ulin are the only covariates having a significant effect
(p\ 0.05) on the variations of TBS. The presence of MS
negatively affected only the association between TBS and
BMD at total hip. We did not find any significant effect of
BMI [35 on TBS values or significant interaction terms
between each covariate and either BMI[35 or the presence
of MS. Obesity negatively affected TBS, despite unchan-
ged BMD. Alterations of glucose homeostasis and sex
hormone levels seem to influence this relationship, while
calciotropic hormones have no role. The effect of waist
circumference on TBS is more pronounced than that of
BMI.
Keywords TBS  Bone quality  Obesity  Metabolic
syndrome  Men
Introduction
The ‘‘trabecular bone score’’ (TBS) is a recently introduced
simple and non-invasive tool able to explore factors
influencing bone strength and fracture risk, other than bone
mineral density (BMD) [1, 2]. The geometry of bone,
micro-architecture, as well as bone micro-damage and bone
mineralization strongly correlate to bone properties, but
each of them is difficult to assess in routine clinical prac-
tice, so that the measurement of BMD still remains the
cornerstone of bone evaluation. The TBS has been reported
to indirectly reflect bone micro-architecture. It is a texture
parameter seemingly recording pixel gray-level variations
in DXA images. The software can be easily installed on
DXA machines, and the value of TBS can be calculated
retrospectively. Higher scores reflect stronger and more
fracture-resistant micro-architecture, whereas lower scores
indicate poor bone quality and greater susceptibility to
fracture [3].
Several studies so far explored the clinical added value
of TBS over BMD to assess the risk of fragility fractures
[4, 5]. Recently, this tool has also been shown to predict
fracture, independent of probabilities using the FRAX
E. Romagnoli and C. Lubrano have contributed equally to this work.
& Elisabetta Romagnoli
romagnoli.elisabetta@fastwebnet.it
1 Department of Experimental Medicine, Medical
Pathophysiology, Food and Science and Endocrinology
Section, ‘‘Sapienza’’ University of Rome, Rome, Italy
2 Unit of Internal Medicine, ‘‘Casa Sollievo della Sofferenza’’
Hospital I.R.C.C.S., San Giovanni Rotondo, FG, Italy
3 Faculty of Economics, UNINT University, Rome, Italy
4 Endocrinology Unit, Department of Movement, Human and
Health Sciences, University of ‘‘Foro Italico’’, Rome, Italy
123
Endocrine
DOI 10.1007/s12020-016-0857-1
Author's personal copy
algorithm [6]. Moreover, in fractured patients with sec-
ondary causes of osteoporosis TBS values are significantly
lower than in patients without fractures [7–9]. In addition,
TBS change following different bone treatments [10, 11].
However, the larger body of literature focused on
women [4, 5], whereas data on TBS in men are still limited.
Two recent papers showed that, consistently with the
results obtained in postmenopausal women, men with
fractures had lower TBS values than men without fractures
[12, 13]. Moreover, TBS and prevalent radiographic ver-
tebral fracture are associated with incident major osteo-
porotic fractures in older men independent of each other
and FRAX 10-year fracture risks [14].
To our knowledge, clinical factors influencing TBS have
not been adequately explored in men. In particular, the
effect of obesity could differ between sexes, due to the
different pattern of fat distribution. Therefore, we investi-
gated the role of overweight and obesity, as of some related
hormonal and metabolic parameters on TBS, in a sample of
men with a wide range of age and BMI.
Methods
In this retrospective cross-sectional study, 141 overweight/
obese men admitted to the day-hospital of our department
from January to September 2014, were initially examined.
They had been consecutively recruited as a part of an
ongoing study aimed to evaluate metabolic and hormonal
profile in male relatives of patients with obesity, insulin
resistance and/or type 2 diabetes mellitus. The study was
approved by the local Ethics Committee, and all partici-
pants gave informed consent. All men underwent complete
medical history and physical examination. From the whole
sample, 18 subjects were excluded because of an history of
spinal surgery, or two or more lumbar vertebrae not
observable on DXA images, or scoliosis of lumbar spine,
10 because they were taking for more than one-year drugs
commonly influencing bone metabolism, 21 because of a
diagnosis of type 2 diabetes mellitus, five because of a
secondary cause of bone loss (endogenous hypercorti-
solism in two subjects, primary hyperparathyroidism in one
subject, suppressed TSH levels in two subjects). A sample
of 87 men (mean age 53.42 ± 11.89 years, range 25–76
years) was finally evaluated. The presence of metabolic
syndrome (MS) was diagnosed according to standard cri-
teria [15]. Anthropometric measurements included weight,
height, waist and hip circumference. Such circumferences
(to the nearest 0.5 cm) were measured using a plastic tape
meter at the level of the umbilicus and of the greater tro-
chanters, respectively. BMI was calculated as weight in
kilograms divided by the square of height in meters (kg/
m2). Waist to hip ratio (W/H) was also calculated. On a
fasting blood sample routine biochemical parameters,
glucose (FPG), insulin, HbA1c, total testosterone, estradiol
(only in 35 subjects), sex hormone binding globulin
(SHBG), parathyroid hormone (PTH), and 25-hydroxyvi-
tamin D (25OHD) were measured according to standard
laboratory methods at ‘‘Policlinico Umberto I’’ University
Hospital of Rome. Free and bioavailable testosterone were
calculated from SHBG, albumin and total testosterone, by
the widely employed formula by Vermeulen et al. [16]
(http://www.issam.ch/freetesto.htm). Homeostasis model
assessment of insulin resistance (HOMA-IR) was calcu-
lated from fasting plasma insulin and glucose levels using
the formula: insulin 9 glucose/22.5 (mU/L 9 mmol/L).
BMD was measured by DXA (QDR Discovery Acclaim,
Hologic Inc., Waltham, MA) at the lumbar spine in pos-
terior-anterior projection (L1–L4) (LS-BMD) and at total
hip (TH-BMD) in all subjects. The coefficients of varia-
tions were 1.0 % at lumbar spine and 1.7 % at total hip.
TBS was evaluated in the same regions used for LS-BMD
(L1-L4) using the latest version of TBS iNsight (version
2.1.2, Med-Imaps, Pessac, France) proved also for men.
TBS was calculated as the mean value of the individual
measurements for vertebrae L1–L4. The coefficient of
variation for TBS was 1 %, and it did not vary among the
measured vertebrae.
Statistical analysis
Data are expressed as mean ± standard deviation or n (%).
One-way analysis of variance (ANOVA) was used to test
differences among groups. Simple correlation coefficients
were computed for all the variables. Kendall’s correlation
was computed either controlling for age and BMI (model
1), or controlling for age and waist circumference (model
2), or for age and waist/hip ratio (model 3), to assess the
association between TBS and the other variables. Kendall’s
thau was used due to its robustness as a measure of cor-
relation and to the possibility to use it in a non-parametric
framework to test for absence of correlation. Correlation
matrices were computed on the whole sample and in sub-
jects with a BMI lower or greater than 35. Such a con-
servative cut-off level of BMI was chosen because it has
been claimed that above this value the effect of obesity
may potentially degrade the reliability of TBS measure-
ment [2].
To analyze the effect of several covariates on TBS,
analysis of covariance models was applied to the three
models considered (model 1, 2, and 3). In all the models,
interaction terms between the covariate and the dummy
variables BMI[35 (yes, no) and metabolic syndrome (yes,
no) have been considered. All the covariates, in turn, were
considered one by one, fitting as many models as the
number of covariates. The goodness of fit of each model
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was assessed via the adjusted r-square index. Hypothesis of
normality of the errors was visually assessed on the
residuals.
In all the analysis a p value of 0.05 was used as a sta-
tistical threshold to indicate a statistically significant effect.
All the analyses have been carried out using R version
3.0.2.
Results
Table 1 summarizes the characteristics of the study sub-
jects, both in the whole sample and in subjects subdivided
according to BMI values: 25.3 % of men were normal/
overweight (BMI Kg/m2 B29.9), 34.5 % were moderately
obese (BMI between 30 and 35) and 40.2 % were severely
obese (BMI C35). Mean TBS values significantly
decreased to the increase of BMI (p\ 0.001 by one-way
ANOVA), while age and LS-BMD did not differ among
the three groups.
In the whole sample, TBS values negatively correlated
with age (r = -0.235, p\ 0.05), BMI (r = -0.452,
p\ 0.0001), waist (r = -0.578, p\ 0.0001), and W/H
(r = -0.403, p\ 0.001). TBS positively associated to LS-
BMD (r = 0.367, p\ 0.001) but not with TH-BMD.
Moreover, TBS negatively correlated with FPG
(r = -0.325, p\ 0.01), fasting insulin (r = -0.228,
p\ 0.05), HbA1c (r = -0.302, p\ 0.01), and HOMA-IR
(r = -0.246, p\ 0.05). TBS also showed a significant
positive correlation with total (r = 0.265, p\ 0.05), free
(r = 0.371, p\ 0.001), and bioavailable testosterone
(r = 0.428, p\ 0.001), whereas it negatively correlated
with SHBG (r = -0.241, p\ 0.05). TBS did not correlate
with estrogen, nor with 25(OH)D and PTH serum levels.
Both in the whole sample, and in subjects grouped for
BMI value (B or [35), the correlation analysis between
TBS and the parameters studied corrected for age and BMI
(model 1), for age and waist circumference (model 2) and
for age and W/H (model 3) displayed higher values in
model 2. So only the result concerning model 2 have
Table 1 Characteristics of study subjects
Parameters Whole sample
n = 87
BMI B29.9
n = 22
30 B BMI\ 35
n = 30
BMI C35
n = 35
p
Age (years) 53.42 ± 11.89 54.40 ± 11.58 52.70 ± 12.27 53.42 ± 12.04 ns
Waist circumference (cm) 114.03 ± 14.39 99.19 ± 8.63 110.55 ± 7.87 126.48 ± 11.10 \0.001
Waist/hip circumference ratio 1.010 ± 0.06 0.982 ± 0.06 1.003 ± 0.05 1.035 ± 0.06 \0.05
Body mass index (BMI)(Kg/m2) 33.79 ± 5.66 26.52 ± 1.93 32.54 ± 1.20 39.43 ± 3.03 \0.001
TBS 1.23 ± 0.13 1.31 ± 0.10 1.25 ± 0.12 1.16 ± 0.14 \0.001
LS-BMD (g/cm2) 1089 ± 0168 1017 ± 0.164 1101 ± 0148 1124 ± 0176 ns
TH-BMD (g/cm2) 1064 ± 0163 0952 ± 0127 1049 ± 0147 1146 ± 0154 \0.001
Glucose (mmol/l) 5.89 ± 1.95 5.17 ± 0.68 6.08 ± 2.40 6.19 ± 2.00 ns
Insulin (pmol/l) 129.3 ± 99.18 70.67 ± 78 100.97 ± 68.22 188.94 ± 103.26 \0.001
HbA1c (%) 4.94 ± 1.16 4.28 ± 0.46 5.11 ± 1.20 5.23 ± 1.24 \0.01
HOMA-IR 6.10 ± 6.35 2.77 ± 3.07 4.43 ± 3.04 9.55 ± 8.14 \0.001
Total testosterone (nmol/l) 3.72 ± 1.34 4.09 ± 1.35 3.90 ± 1.34 3.30 ± 1.27 ns
Free testosterone (ng/dl) 7.26 ± 2.88 8.48 ± 3.2 7.40 ± 2.43 6.34 ± 2.83 \0.05
Bioavailable testosterone (ng/dl) 171.44 ± 67.18 199.21 ± 73.47 175.65 ± 59.06 149.32 ± 64.6 \0.05
Estradiol (pmol/l)a 99.85 ± 38.43 81.16 ± 33.4 97.46 ± 35.79 110.42 ± 41.04 ns
SHBG (nmol/l) 36.29 ± 12.73 33.58 ± 9.94 37.63 ± 14.95 36.82 ± 12.26 ns
25(OH)D (ng/ml) 21.02 ± 10.03 26.45 ± 11.96 20.39 ± 5.43 19.15 ± 11.52 \0.05
PTH (pg/ml) 39.98 ± 19.42 33.38 ± 16.93 41.88 ± 22.41 39.09 ± 16.58 ns
Variables are expressed as mean ± SD
BMI body mass index; TBS trabecular bone score; LS-BMD lumbar spine bone mineral density; TH-BMD total hip bone mineral density; HOMA-
IR homeostasis model assessment insulin resistance; SHBG sex hormone binding globulin; 25(OH)D 25-hydroxyvitamin D; PTH parathyroid
hormone
The p values refer to significant differences among the three groups of males subdivided according to BMI range (C29.9, between 30 and 35,
B35)
a Measured in 35 out of 87 subject
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presented (Table 2). In all groups a significant correlation
was found between TBS and LS-BMD. TBS correlated
with TH-BMD only in the whole sample and in subjects
with BMI \35. In the same groups, TBS negatively cor-
related with HbA1c and FPG. Finally, TBS positively
correlated with both free and bioavailable testosterone, and
negatively with SHBG.
The analysis of covariance models shows that model 2
always had a better fitting (measured by the adjusted r-
square index) than those obtained by either model 1 or
model 3 (data not shown). Concerning the effect of each
covariate on TBS, and its possible interaction effects with
MS (y/n) and BMI [35, only LS-BMD, TH-BMD, FPG,
bioavailable testosterone, and SHBG showed a significant
effect (p\ 0.05) on the variations of TBS. MS negatively
affected only the association between TBS and TH-BMD.
We did not find any significant effect of BMI[35 on TBS
or significant interaction terms between each covariate and
either BMI[35 or the presence of MS.
Discussion
We investigated the influence of some anthropometric,
metabolic and hormonal parameters on TBS in a group of
overweight/obese men with a wide range of age, BMI, and
degree of insulin resistance, but without type 2 diabetes
mellitus.
In men of similar mean age, with the increase of BMI,
TBS significantly decreased; on the contrary, LS-BMD did
not vary and TH-BMD progressively increased, so that in
obese men, lower TBS values could reflect a bone quality
deterioration.
Since age and anthropometric variables may strongly
influence the correlations of TBS with all the parameters
investigated, we set-up three different models adjusted for
either age and BMI (model 1), or age and waist circum-
ference (model 2) or age and W/H (model 3). The second
model best fitted our data, showing that TBS significantly
correlated with BMD, HbA1c, free and bioavailable
testosterone, in the whole sample or in subjects with BMI
\35. By the analysis of covariance, this model showed that
at the increase of LS-BMD, TH-BMD and bioavailable
testosterone, TBS values increased, while fasting, glucose
and SHBG had a negative effect on TBS values. In subjects
with MS, TBS was on average lower than in those without
MS.
The contribution of TBS in determining bone properties
has been scarcely investigated in men. Recently, two
papers demonstrated that in men with fractures TBS values
were reduced and predicted incident fractures in older men
[12, 13]. Moreover, in diabetic patients of both genders,
TBS negatively correlated with HbA1c, FPG, fasting
insulin, and HOMA-IR also in men, suggesting that TBS
could be a marker of skeletal deterioration in diabetes [17].
Our results show that TBS relates to metabolic risk factors
also in men without diabetes but with different degree of
insulin resistance. In particular, after adjustment for age
and anthropometric variables, TBS negatively correlated
with HbA1c levels and fasting glucose, implying impaired
bone quality, possibly due to the accumulation of advanced
glycosylation end-products in the organic bone matrix [18].
We also investigated the effect on TBS of metabolic
syndrome. This is a very common condition in obese
patients, whose abdominal fat and insulin resistance may
affect bone. However, the effects of MS on bone health are
still controversial, particularly in clinical studies assessing
BMD, in which the protection afforded by increased body
weight is balanced by the damage due to the inflammatory
state, insulin resistance, hyperglycemia, and other factors
[19, 20]. A recent meta-analysis suggested that MS is a risk
factor for osteoporosis in men [21], probably because of
impaired bone quality. No studies so far assessed the role
of TBS to evaluate bone properties in patients with MS. At
this regard, our results are mostly negative. We did not find
any significant interaction terms between each covariate
and the presence of MS, although it negatively affected the
association between TBS and TH-BMD. In other words,
subjects with MS showed on average a lower value of TBS.
In our study, we also attempted to evaluate the effect of
obesity on TBS assessment. A very large amount of soft
Table 2 Correlation analysis between TBS and the investigated
skeletal, metabolic, and hormonal parameters, corrected for age and
waist circumference (model 2)
Parameter Whole sample BMI B35 BMI[35
LS-BMD 0.334*** 0.358*** 0.436**
TH-BMD 0.226** 0.321** 0.180
Fasting plasma glucose -0.147 -0.276** -0.02
Fasting insulin -0.017 -0.027 0.014
HbA1c -0.249** -0.268* -0.177
HOMA-IR -0.050 -0.089 -0.006
Total testosterone 0.074 0.087 -0.014
Free testosterone 0.172* 0.147 0.082
Bioavailable testosterone 0.194* 0.169 0.124
SHBG -0.209* -0.164 -0.269
25[OH]D -0.092 -0.111 -0.055
PTH 0.053 0.037 0.111
Data are presented in the whole sample and in subjects subdivided
according to BMI, lower or higher than 35
LS-BMD lumbar spine bone mineral density; TH-BMD total hip bone
mineral density; HOMA-IR homeostasis model assessment insulin
resistance; SHBG sex hormone binding globulin; 25(OH)D 25-hy-
droxyvitamin D; PTH parathyroid hormone
* p\ 0.05; ** p\ 0.01;*** p\ 0.001
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tissue overlying ROI may potentially degrade image
quality and affect texture analysis, reducing the TBS esti-
mate in obese subjects. Therefore, it is claimed that the
better performance of TBS is obtained when BMI ranges
from 15 to 35 kg/m2, and TBS assessment is not validated
beyond these limits of BMI [2]. Actually, this manufac-
turer’s recommendation for TBS software does not rely on
published data. It cannot be excluded that TBS could
capture alterations in bone structure of obese individuals,
who may have higher fracture risk despite a higher BMD
[22]. On the other hand, BMI can not adequately reflect
central abdominal fat or distinguish it from adiposity at
other sites. Moreover, due to the difference in fat tissue
distribution and muscle weight, the adjustment for BMI
could not work equally well in men and women. Actually,
studies evaluating the influence of BMI on TBS provided
discordant results. In older women, the negative correlation
between TBS and BMI was attenuated after excluding
obese individuals with BMI[30 kg/m2 [23]. On the other
hand, TBS was significantly lower in the diabetic than
nondiabetic women, when stratifying results by obesity
[24]. Therefore, we evaluated not only the influence on
TBS of BMI[35 (the current cut-off for TBS reliability)
but also that of waist circumference and W/H, two easy-to-
perform measures of abdominal fat accumulation. This
represents a relevant novel approach, since no studies
hitherto considered the influence of abdominal fat on TBS
values. Simple models showed better correlations between
TBS and other parameters when controlling for age and
waist circumference, in respect to models controlled for
either age and BMI or age and W/H. Noteworthy, the
results of covariance analysis showed that model 2 pro-
vided an adjusted r-square index always higher than the
other models. This implies an increase in the explained
variance of TBS when controlling for age and waist cir-
cumference. Collectively, our data indicate that TBS
assessment does not provide reliable results in subjects
with BMI[35, but below this BMI the model adjusting for
waist circumference better fitted the data. Therefore, waist
circumference, instead of BMI, should be probably taken
into account when assessing TBS performance in obese
men. Conceivably, central obesity, mirrored by waist cir-
cumference, may affect skeletal health more than general
obesity reflected by BMI [25]. On the other hand, previous
results on the association between waist circumference and
BMD have been inconsistent. Gonnelli demonstrated that
fat distribution differently affects BMD in men and
women: android fat is positively associated with BMD at
different skeletal sites in men, whereas in women BMD at
the same skeletal sites is negatively associated with gynoid
fat [26]. On the contrary, waist circumference was nega-
tively and independently associated with lumbar spine and
femoral neck BMD in men [27]. Differences in the
populations studied, in the methods used to measure BMD
and central adiposity, or in the number and type of
covariates controlled for across studies may account for
these divergent findings [28].
Besides, the association between TBS and sex hormones
deserves interest. TBS significantly correlated with both
free and bioavailable testosterone and negatively with
SHBG. The analysis of covariance also showed a positive
effect of bioavailable testosterone and a negative one of
SHBG on TBS. The effects of sex steroids in male bone
health are complex and incompletely known. Our results
are in line with a recent study demonstrating that men with
abdominal obesity have impaired bone micro-architecture
and strength as measured by HR-pQCT at distal radius
[25].
Our study has some limitations. Firstly, the cross-sec-
tional design of the study allows investigating for associ-
ation and not for causality. Secondly, sample size was
relatively small. Moreover, the lack of comparison with
women does not allow infer whether gender-related dis-
tribution of body fat differently affects TBS measurement
in men and women [29]. Finally, due to the retrospective
design of the study, not all confounding factors have been
considered and sex hormone levels were measured by
commercial assays which lack the reliability of newer
liquid chromatography tandem mass spectrometry methods
[30].
In conclusion, our data showed that abdominal fat
accumulation could negatively affect TBS values in over-
weight/obese men, independent of LS-BMD. Parameters of
glucose homeostasis and sex hormone levels seem to
influence TBS, at least in this group. Moreover, for the first
time, we also demonstrated that waist circumference did
influence TBS values more than BMI, contrary to current
beliefs. This latter finding could be relevant when inves-
tigating bone quality in obese men.
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